
Cannasouth Investor Relations Material
Latest events

Investor Day 2023
Cannasouth

H2 2023
29 Feb, 2024

Trading Update
23 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cannasouth Limited
Access all reports
Cannasouth Limited is a biopharmaceutical company focused on the research, development, and commercialization of medicinal cannabis products. The company operates in areas such as cannabinoid extraction, formulation, and clinical research to create therapeutic products for various health conditions. Cannasouth also engages in cultivation and processing through joint ventures, aiming to ensure high-quality, sustainably produced raw materials for its products. The company is headquartered in Hamilton, New Zealand, and its shares are listed on the NZX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CBD
Country
🇳🇿 New Zealand